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Abstract 
We present two patients with hepatic lesions associated with congenital portosystemic 
shunts (CPSS), a rare vascular malformation, in order to emphasize the variable 
clinical presentation of this condition and different management strategies in each 
case. CPSS can give rise to several complications such as hepatic encephalopathy, 
portopulmonary hypertension and hepatic tumors. These hepatic lesions though most 
commonly benign in nature have an increased risk of malignant transformation. 
Therefore, we underline the necessity of considering CPSS in the differential 
diagnoses for all cases of space-occupying hepatic lesions in pediatric patients. 
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Abbreviations:  
CPSS: Congenital portosystemic shunts   
IVC: Inferior vena cava  
FNH: Focal nodular hyperplasia 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aristotle Biomedical Journal, Vol 2, No 1 e-ISSN: 2653-9748 
86 
Introduction 
Congenital portosystemic shunts 
(CPSS) are rare vascular 
malformations creating abnormal 
connections between the portal and the 
systemic venous systems, diverting the 
blood flow away from the liver and 
into the systemic circulation. This is 
probably due to incomplete or lacking 
involution of the primordial abdominal 
embryonic veins (Franchi-Abella et 
al.,2018). CPSS are often associated 
with other malformations; involving 
the cardiovascular system most 
commonly and genetic disorders such 
as Down and Turner syndromes. The 
most common members of the 
systemic venous circulation involved 
are the inferior vena cava (IVC) and 
the right atrium. CPSSs can be single 
or multiple, intrahepatic or 
extrahepatic and can vary in size from 
case to case.  Extrahepatic CPSS are 
also known as Abernethy 
malformations, named after Dr. J. 
Abernethy who first described a 
malformation of this kind. CPSS may 
also be due to a persistent or patent 
ductus venosus which many authors 
categorize on its own, as it is due to the 
persistence of the fetal circulation 
pattern (Bernard et al.,2012). Imaging 
modalities remain the mainstay tools 
for diagnosis of CPSS, with ultrasound 
Doppler imaging being the gold 
standard for both diagnosis, as well as 
follow up before, during and after 
treatment (Timpanaro et al.,2015).  
CPSS can lead to a wide variety of 
complications and has an equally large 
range of clinical presentations making 
its diagnosis particularly difficult. The 
main and most clinically important 
complications include: hepatic 
encephalopathy with hyperammonemia 
and delayed mental development or 
learning difficulties, liver tumors, 
portopulmonary hypertension and its 
consequences and pulmonary 
arteriovenous shunts formation. Some 
CPSS may remain asymptomatic for 
decades but carry the risk of hepatic 
lesions development, as seen in the 
following two cases (Bernard et 
al.,2012).  
Case 1:  
A six year old male patient (patient A) 
presented at our clinic with intermittent 
abdominal pain for more than six 
months, located in the periumbilical 
region and no other gastrointestinal 
symptoms. The parents reported a 
history of periodic atypical abdominal 
pain episodes for the past two years. 
The pain had no association with the 
timing of food intake or specific foods. 
During the clinical and laboratory 
investigation, elevated liver 
transaminases were noted and 
ultrasound and MRI imaging revealed 
three hepatic lesions rapidly increasing 
in size, as well as a wide shunt 
between the right portal vein branch 
and the inferior vena cava (Figures 1 
and 2). An open biopsy of the lesions 
was performed, a tissue sample sized 
1.5cm was taken and sent for 
histopathologic examination, which 
revealed an atypical hyperplastic 
nodular lesion; consistent with focal 
nodular hyperplasia (FNH) of the liver. 
The postoperative period was 
uneventful and the patient was 
discharged three days postoperatively. 
Since no major complications were 
present it was decided that the best 
option at the time was to continue 
conservatively. We are monitoring the 
patient closely and we are in the 
process of designing an appropriate 
plan for closure of the shunt to avoid 
portal hypertension and possible 
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Figure 1: Patient A. MRI visualizing communication between the right portal brunch and the 
inferior vena cava (IVC). 
 
 
 
Figure 2: Patient A. MRI presenting a wide shunt between the right branch of the portal vein 
and the IVC. 
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hepatic failure. Until now, the patient’s 
status remains unchanged and no 
further actions have been taken. 
 
Case 2: 
A seven year old male (patient B) 
presented at the pediatric clinic of our 
hospital with gastrointestinal 
disturbances. Gastroscopy was 
performed which revealed active 
gastritis. In the patient’s medical 
history galactosemia (not clinically 
proven) was reported, as well as, 
hyperbetalipoproteinemia, behavioral 
changes and hyperactivity. Blood 
testing revealed elevated liver enzymes 
and coagulation disturbances. The 
patient was put on medical therapy 
with vitamins K, H and A, as well as 
lactulose. Ultrasound imaging showed 
an intrahepatic shunt between the IVC 
and the right branch of the portal vein 
and 3-4 hyperechoic lesions in the 
right hepatic lobe (Figures 3-5). MRI 
investigation revealed multiple hepatic 
lesions with increased MR sign in the 
T1 sequences; (Differential diagnosis: 
regenerative lesions, multifocal 
nodular hyperplasia) and shunting 
between the right portal vein branch 
and the right hepatic vein. Biopsy of 
the lesions showed an atypical form of 
focal nodular hyperplasia with no signs 
of associated malignancy. The patient 
was discharged on day 6 
postoperatively and during follow up 
his condition remained unchanged 1 
month later. Due to the altered hepatic 
function and coexisting coagulation 
disturbances seen on presentation, the 
patient was considered a good 
candidate for liver transplantation and 
was put on the national transplantation 
register. 
 
 
Discussion  
The incidence of 1 in 30 000 births 
reported in neonates becomes 1 in 50 
000 in patients over one year old, due 
to a great percentage of spontaneous 
closure of the shunt seen within the 
first year of life. In children not 
diagnosed during prenatal ultrasound 
examinations, a CPSS may be 
diagnosed as an incidental finding 
during ultrasound or other imaging 
examination for an unrelated condition 
or due to complications. 
The increasing diagnostic sensitivity of 
ultrasound imaging has led to earlier 
diagnosis of CPSS and better planning 
of subsequent treatment. Once a CPSS 
has been confirmed additional 
information about its location and 
structures involved, as well as 
investigation for the existence of any 
hepatic lesions, can be given by a CT 
and/or MRI scan (Franchi-Abella et 
al.,2018). Angiography can be used to 
perform an occlusion test to reveal 
possible development of portal 
hypertension after closure of the shunt 
or for permanent occlusion of the shunt 
if deemed appropriate (Timpanaro et 
al.,2015).    
These lesions can be single or multiple 
and are seen with all anatomic types of 
CPSS. Histologically these lesions 
include benign tumors such as, 
adenomas, focal nodular dyplasias and 
nodular regeneration hyperplasias, as 
well as malignancies like 
hepatocellular carcinomas, 
hepatoblastomas and sarcomas. It has 
been reported that even benign lesions 
found in the liver of patients with 
CPSS carry a risk of malignant 
transformation which leads to an 
increasing need for accurate diagnosis 
and appropriate management of these 
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Figure 3: Patient B. U/S showing enlargement of the portal vein (PV) due to shunt with the 
IVC. 
 
Figure 4: Patient B. U/S with Doppler imaging showing portosystemic shunt. 
 
Figure 5: Patient B. U/S presenting a mass in proximity with the IVC, histologically found to 
be focal nodular hyperplasia.
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patients (Franchi-Abella S. et 
al.,2018).  
It has been proposed that CPSS leads 
to poor portal flow, the reduced 
mesenteric blood return to the liver 
reduces the levels of insulin and 
glucagon passing through the liver 
parenchyma and the regenerative 
abilities of the liver. This leaves the 
liver vulnerable to both benign and 
malignant tumor formation (Lautz T.B. 
et al., 2016). All of the above are 
supported by the findings of benign 
nodules regression, even 
disappearance, after successful closure 
of the portosystemic shunt and 
establishment of the physiologic portal 
blood flow (Bernard et al. 2012). 
Bernard et.al (2012) in their review of 
265 children diagnosed with CPSS 
have recorded 64 patients with 
associated hepatic tumors of which 26 
were single and 38 multiple, histologic 
examinations showed mainly benign 
lesions such as FNH and nodular 
regenerative hyperplasia, while 7 cases 
were found to have malignant tumors. 
Two of these were found during follow 
up of previously known adenomas or 
nodular regenerative hyperplastic 
lesions and all malignancies were 
associated with extrahepatic CPSS. In 
21 of these cases were the shunt was 
closed without tumor resection, the 
masses either significantly regressed or 
disappeared after closure of the CPSS. 
Lautz et al. (2016) reported two cases 
with concurrent CPSS and 
hepatoblastomas, the patients 
presented with normal liver enzymes, 
rapidly enlarging hepatic mases and 
increased levels of αFP. Similar cases 
were also reported by Marois et al 
(1979), Barton and Keller (1989), 
Kawano et al. (2007) and Loomba et 
al. (2012) which further emphasizes 
the possibility of malignant tumor 
development in patients with CPSS, 
especially extrahepatic CPSS. Small 
liver masses with normal αFP levels 
can be safely monitored but enlarging 
masses must be biopsied (Lautz et 
al.,2016).  
The management of patients diagnosed 
with CPSS, varies according to their 
age at presentation and the presence of 
complications as well as their severity. 
For asymptomatic infants under the 
age of one, a conservative approach of 
serial follow ups is proposed as there is 
an increased chance of spontaneous 
regression within the first year of life 
(Chocarro et al., 2016). Symptomatic 
patients especially those with 
hyperammonemia and pulmonary 
hypertension closure of the shunt either 
surgical or percutaneous in a one- or 
two-stage procedure is recommended 
as soon as possible to ensure minimal 
progression of their condition 
(Franchi-Abella et al.,2010). In the 
case of patients who present with 
hepatic lesions, benign lesions have 
been shown to regress considerably or 
even disappear after closure of the 
CPSS (Blanc et al.,2014). Hepatic 
malignancies associated with CPSS, 
must be resected when possible 
followed by adjuvant chemotherapy or 
if deemed unresectable, neoadjuvant 
treatment can be given followed by 
tumor resection if successful. Liver 
transplantation may also be a viable 
choice for patients presenting with 
malignant hepatic lesions and CPSS as 
it resolves at once both the malignancy 
and the CPSS issue, however lifelong 
immunosuppression is an issue in this 
case and it must be taken into 
consideration (Lautz et al.,2016). 
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